Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Cell Biochem ; 116(7): 1256-66, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25581839

ABSTRACT

In this paper we have studied a PDZ protein domain as a possible tool for cellular targeting of the ribosome inactivating protein Saporin, exploiting the ability of PDZ domains to recognize and bind short peptide sequences located at the C-terminus of a cognate protein. We have focused our attention on the PDZ domain from hCASK (Human calcium/calmodulin-dependent serine protein kinase) that binds extracellular CD98 in epithelial cells, being this antigen recognized as a marker for several human tumors and particularly considered a negative prognostic marker for human glioblastoma. We produced recombinant fusions of one or two hCASK-PDZ domains with the ribosome inactivating protein Saporin and assayed them on two human glioblastoma cell lines (GL15 and U87). These constructs proved to be toxic, with increasing activity as a function of the number of PDZ domains, and induce cell death by apoptotic mechanisms in a dose-dependent and/or time dependent manner.


Subject(s)
Fusion Regulatory Protein-1/metabolism , Guanylate Kinases/genetics , Immunotoxins/pharmacology , Ribosome Inactivating Proteins, Type 1/pharmacology , Apoptosis , Cell Line, Tumor , Fusion Regulatory Protein-1/chemistry , Glioblastoma/drug therapy , Glioblastoma/immunology , Guanylate Kinases/chemistry , Guanylate Kinases/metabolism , Humans , Immunotoxins/genetics , Immunotoxins/metabolism , Molecular Targeted Therapy , PDZ Domains , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Ribosome Inactivating Proteins, Type 1/genetics , Ribosome Inactivating Proteins, Type 1/metabolism , Saporins
SELECTION OF CITATIONS
SEARCH DETAIL